IPEC Europe unveils its new visual identity “Dialogue” to reflect the essence of how the association operates.
The association celebrates its 25th Anniversary with a special forum.
IPEC Europe establishes its Secretariat with headquarters in Brussels, Belgium.
A fifth regional IPEC is created in India to play a greater role in the evolution and development of the excipient industry in this country.
IPEC Europe is a founding member of and an active contributor to EXCiPACT, a not-for-profit organisation that develops and manages a 3rd party certification scheme for manufacturers, suppliers and distributors of pharmaceutical excipients.
The TriPEC structure evolves into the IPEC Federation, a global association consisting of regional associations organised to promote quality in excipients and legally registered in Belgium.
Inaugurated in Hong Kong, IPEC China is the association representing the excipient industry in the People’s Republic of China.First publication of joint IPEC-PQG Good Manufacturing Practices Audit Guideline
IPEC Europe, IPEC-Americas and PQG publish the first Good Manufacturing Practices Audit Guideline.First publication of IPEC Europe Good Distribution Practices Audit Guideline
IPEC Europe publishes the first Good Distribution Practices Audit Guideline.
The first guide to produce appropriate standards for the manufacturing of excipients for pharmaceutical use aligned with ISO:9001 is jointly published by IPEC Europe, IPEC-Americas and the PQG in January.
IPEC Europe provides expertise on excipients during the development of the first edition of the World Health Organisation (WHO) Good Trade and Distribution Practice for Pharmaceutical Starting Materials guideline.Collaboration with the Pharmaceutical Quality Group
IPEC Europe and IPEC-Americas enter into an arrangement with the Pharmaceutical Quality Group (PQG), an organisational unit of the UK-based Institute of Quality Assurance.
IPEC publishes the first Good Manufacturing Practices Audit Guideline for Distributors of Bulk Pharmaceutical Excipients.First IPEC Europe newsletter
The first newsletter of IPEC Europe is published in January.
IPEC Europe launches its first website, jumping in the world wide web.
The Safety Committee elaborated the Guidelines for Safety Evaluation of Excipients, published in European Pharmaceutical Review
IPEC Europe and IPEC-Americas jointly adopt, publish and implement industry-developed Good Manufacturing Practices (GMP) for Bulk Pharmaceutical Excipients.
An updated version of this guidance has been adopted by the World Health Organisation and by the United States Pharmacopoeia.
IPEC Europe, together with IPEC Japan and IPEC-Americas, creates the TriPEC group as a forum to discuss global excipient harmonisation.
IPEC Europe is officially created on 7 April 1992 in France.
The founding members of IPEC Europe are Colorcon, Dow Corning, Ciba Geigy, Seppic, Aqualon, Smith Kline Beecham. Mr John Hogan, Colorcon is appointed as the first Chairman.
In parallel, another regional IPEC is founded in Japan as JPEC in February.
A one-day seminar is organised in Paris during the spring.
The IPEC (later IPEC-Americas) is created in the U.S. with four basic goals: